ArticleClinical and experimental immunology2025

Amlexanox targeted inhibition of TBK1 regulates immune cell function to exacerbate DSS-induced inflammatory bowel disease.

Lu Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.